Immuneering IMRX
NASDAQ IMRX
$4.14 +0.05 (+1.10%)
As of: Oct 1, 2026 · 1:49 PM EDT

Immuneering (IMRX) Gross Profit (2020 - 2022)

Updated

Immuneering (IMRX) recorded Gross Profit of $455.00 in Q4 2022, compared with -$16,630 a year earlier and down 97.6% from the prior quarter.

Analysis

Immuneering (IMRX) Gross Profit (2020 - 2022) Analysis & Trends

For FY2022, Immuneering reported Gross Profit of $158,830, down 82.9% from FY2021.

  • Across earlier years, Gross Profit came in at $926,888 in FY2021 (-10.1%) and $1.03 million in FY2020.
  • Quarterly Gross Profit has ranged from -$16,630 in Q4 2021 to $367,568 in Q3 2020 over the past five years.
  • On a year-over-year basis, Gross Profit rose in 1 of the last five quarters, with an average decline of 48.0%.
  • Per Business Quant, the preceding three quarters came in at $19,037 (Q3 2022), $46,486 (Q2 2022) and $92,852 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immuneering 264.61 Mn 264.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 455.00
Sep 30, 2022 19,037.00
Jun 30, 2022 46,486.00
Mar 31, 2022 92,852.00
Dec 31, 2021 -16,630.00
Sep 30, 2021 263,042.00
Jun 30, 2021 341,439.00
Mar 31, 2021 339,037.00
Dec 31, 2020 191,847.00
Sep 30, 2020 367,568.00
Jun 30, 2020 243,773.00
API Access

Immuneering Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=IMRX&period=max&api_key=YOUR_API_KEY